As expected, IFITM3 was found to be highly correlated with most immune checkpoints in BLCA, including CD274, PDCD1, and CTLA4 (Figure 2G, Supplementary Figure S4G). The gene discussed is CD274; the disease is bladder transitional cell carcinoma.